Collaboration could be the mantra to drive significant gains in artificial intelligence (AI), clinical research and drug approvals, executives at Parexel International Corp., a major global provider of biopharma services including contract research, told Scrip in an interview that reveals insights across geographies and functional areas of expertise.
Chief strategy officer Kushal Gohil, based in the US, UK-based executive vice-president (EVP), Clinical Data and Digital Services, Stephen Pyke, and EVP and managing director for India, Sanjay Vyas, based in the country, shared their views on
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?